A detailed history of Silicon Valley Capital Partners transactions in Bio Techne Corp stock. As of the latest transaction made, Silicon Valley Capital Partners holds 376 shares of TECH stock, worth $27,459. This represents 0.0% of its overall portfolio holdings.

Number of Shares
376
Previous 376 -0.0%
Holding current value
$27,459
Previous $26,000 15.38%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 29, 2024

BUY
$62.12 - $84.15 $62 - $84
1 Added 0.27%
376 $26,000
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $19,811 - $29,332
375 New
375 $28,000
Q1 2023

May 09, 2023

BUY
$71.62 - $86.62 $0 - $0
0 New
0 $0
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $0 - $0
0 New
0 $0

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.86B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Silicon Valley Capital Partners Portfolio

Follow Silicon Valley Capital Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silicon Valley Capital Partners, based on Form 13F filings with the SEC.

News

Stay updated on Silicon Valley Capital Partners with notifications on news.